Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, Phase II trials
10.1080/21645515.2019.1578595
Saved in:
Main Authors: | Ngoc Huu Tran, Danaya Chansinghakul, Chia Yin Chong, Chian Yong Low, Lynette P Shek, Chan Quang Luong, Carina Fargo, T. Anh Wartel, Sunny Sun, Anna Skipetrova, Alain Bouckenooghe |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
Taylor & Francis
2019
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/162078 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Long-term safety follow-up of children from a randomized - Controlled phase II b proof - Of - concept efficacy study of the live, attenuated, tetravalent dengue vaccine (CYD - TDV) in Thailand
by: Kriengsak Limkittikul, et al.
Published: (2020) -
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine
by: Wilder-Smith, Annelies, et al.
Published: (2016) -
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial
by: Arunee Sabchareon, et al.
Published: (2018) -
Low antibody titers five years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
by: Velumani, Sumathy, et al.
Published: (2016) -
Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naive vaccinees
by: Velumani, Sumathy, et al.
Published: (2022)